David K. Erickson | Edwards Lifesciences Corp. |
Michael A. Mussallem | Edwards Lifesciences Corp. |
Scott B. Ullem | Edwards Lifesciences Corp. |
Bob Hopkins | Bank of America Merrill Lynch |
Isaac Ro | Goldman Sachs & Co. LLC |
Lawrence Biegelsen | Wells Fargo Securities LLC |
David Ryan Lewis | Morgan Stanley & Co. LLC |
Anthony Petrone | Jefferies LLC |
Jason Richard Mills | Canaccord Genuity, Inc. |
Vijay Kumar | Evercore ISI |
Christopher Pasquale | Guggenheim Securities LLC |
Joanne Karen Wuensch | BMO Capital Markets (United States) |
Glenn John Novarro | RBC Capital Markets LLC |
Frederick Wise | Stifel, Nicolaus & Co., Inc. |
Bruce M. Nudell | SunTrust Robinson Humphrey, Inc. |
Joshua Jennings | Cowen & Co. LLC |
Danielle Antalffy | Leerink Partners LLC |
Robert J. Marcus | JPMorgan Securities LLC |
Greetings, and welcome to the Edwards Lifesciences Second Quarter 2018 Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, David Erickson, Vice President-Investor Relations.